Details view | IP Australia | Trade Mark Search

Additional fields:
Address History and Publication details Endorsements as at 10 November 2018 Opposition details

IR number	1829883
Words	AYRFLUMO
Image
Image description
Status	protected: Registered/protected
Priority date	17 May 2024 (Convention)
Class	5
Kind	Word

Dates
Renewal due	14 Nov 2034
Registration advertised / published	26 May 2025
Entered on Register	26 May 2025
Acceptance advertised / published	19 Mar 2025
Acceptance	19 Mar 2025
IR notification	26 Dec 2024
Filing	14 Nov 2024
Registered from	14 Nov 2024

Owner	Address for service
GlaxoSmithKline Biologicals S.A. Rue de l'Institut 89 B-1330 Rixensart BELGIUM	Davies Collison Cave Pty Ltd Level 28 500 Bourke Street MELBOURNE, VIC, 3000 AUSTRALIA

IR Contact
Legal Brand Protection Corporate Intellectual Property, GSK HQ, 79 New Oxford Street London WC1A 1DG UNITED KINGDOM

IR Contact

Legal Brand Protection

Class 5: Pharmaceutical and medicinal preparations and substances; vaccines.

Endorsements	Provisions of paragraph 44(3)(b) and/or Reg 4.15A(3)(b) applied. The applicant has advised that the words in the Mark have no meaning in English

Endorsements

Provisions of paragraph 44(3)(b) and/or Reg 4.15A(3)(b) applied.

The applicant has advised that the words in the Mark have no meaning in English

Word

AYRFLUMO

Image

Australian Trade Mark Search